Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4

dc.contributor.authorJenkins, Paul R.
dc.contributor.authorWilson, J.
dc.contributor.authorEmmerson, Daniel
dc.contributor.authorGarcía, M. D.
dc.contributor.authorSmith, M. R.
dc.contributor.authorGray, S. J.
dc.contributor.authorBritton, R. G.
dc.contributor.authorMahale, S.
dc.contributor.authorChaudhuri, B.
dc.date.accessioned2009-11-05T16:55:47Z
dc.date.available2009-11-05T16:55:47Z
dc.date.issued2008
dc.identifier.citationJenkins PR, Wilson J, Emmerson D, Garcia MD, Smith MR, Gray SJ, Britton RG, Mahale S, Chaudhuri B. (2008) Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4. Bioorganic and Medicinal Chemistry, 16 (16) pp. 7728-7739en
dc.identifier.doihttps://doi.org/10.1016/j.bmc.2008.07.002
dc.identifier.issn0968-0896
dc.identifier.urihttp://hdl.handle.net/2086/2794
dc.language.isoenen
dc.peerreviewedYesen
dc.publisherElsevieren
dc.ref2014.selected1365591152_9910680072956_3_2
dc.researchgroupChemistry for Health
dc.titleDesign, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4en
dc.typeArticleen

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.25 KB
Format:
Item-specific license agreed upon to submission
Description: